Acquisition Opportunity Rare Patient Voice was acquired by Konovo Insights in February 2026, signaling potential for integration of their patient recruitment capabilities with a larger healthcare intelligence platform. This may create upsell opportunities for enhanced recruitment services, data access, or joint research programs with Konovo's clients.

Global Expansion The company expanded its panel to Australia and New Zealand in 2022, indicating a willingness to scale international patient recruitment. This suggests potential for selling broader global recruitment solutions, multilingual outreach, and cross-border study capabilities to clients seeking diverse patient populations.

Financial Strength With reported revenue between ten and twenty-five million dollars and a track record of paying patients over fifteen million since 2013, Rare Patient Voice demonstrates financial viability and reliability as a research partner, supporting opportunities for multi-study engagements and larger contract engagements.

Recognition & Leadership Recent awards and executive recognition, including GHP Global Excellence Award and Insights Association Laureate, bolster credibility for enterprise partnerships and bids, making a case for pursuing larger, strategic deals with pharmaceutical and biotech companies.

Growth & Talent A history of new hires in business development and project management, plus consistent growth reflected in Inc. 5000 listing in 2022, indicates ongoing capacity to handle increased program volume, suggesting readiness for expanding current client programs and onboarding new enterprise accounts.